Pulmonary hemodynamics before and after pediatric heart transplantation

被引:0
作者
Biedermann, Philipp [1 ,2 ,3 ]
Sitte-Koch, Vanessa [1 ,2 ,3 ]
Schweiger, Martin [2 ,3 ,4 ]
Meinold, Anke [2 ,3 ,5 ]
Quandt, Daniel [1 ,2 ,3 ]
Kretschmar, Oliver [1 ,2 ,3 ]
Balmer, Christian [1 ,2 ,3 ]
Knirsch, Walter [1 ,2 ,3 ,6 ]
机构
[1] Univ Childrens Hosp Zurich, Dept Surg, Pediat Cardiol, Zurich, Switzerland
[2] Univ Childrens Hosp Zurich, Childrens Res Ctr, Steinwiesstr 75, CH-8032 Zurich, Switzerland
[3] Univ Zurich, Zurich, Switzerland
[4] Univ Childrens Hosp Zurich, Dept Surg, Pediat Congenital Heart Surg, Zurich, Switzerland
[5] Univ Childrens Hosp Zurich, Pediat Intens Care, Zurich, Switzerland
[6] Univ Childrents Hosp Zurich, Pediat Heart Ctr, Dept Surg, Pediat Cardiol, Steinwiesstr 75, CH-8032 Zurich, Switzerland
关键词
outcome; pediatric heart transplantation; pulmonary hypertension; pulmonary vascular resistance; IN-HOSPITAL MORTALITY; CARDIAC TRANSPLANTATION; INTERNATIONAL SOCIETY; ISCHEMIC TIME; HYPERTENSION; OUTCOMES; MANAGEMENT; CHILDREN; FAILURE; ASSOCIATION;
D O I
10.1111/ctr.15162
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundPulmonary hypertension (PH) may limit the outcome of pediatric heart transplantation (pHTx). We evaluated pulmonary hemodynamics in children undergoing pHTx.MethodsCross-sectional, single-center, observational study analyzing pulmonary hemodynamics in children undergoing pHTx.ResultsTwenty-three children (female 15) underwent pHTx at median (IQR) age of 3.9 (.9-8.2) years with a time interval between first clinical signs and pHTx of 1.1 (.4-3.2) years. Indications for pHTx included cardiomyopathy (CMP) (n = 17, 74%), congenital heart disease (CHD) (n = 5, 22%), and intracardiac tumor (n = 1, 4%). Before pHTx, pulmonary hemodynamics included elevated pulmonary artery pressure (PAP) 26 (18.5-30) mmHg, pulmonary capillary wedge pressure (PCWP) 19 (14-21) mmHg, left ventricular enddiastolic pressure (LVEDP) 17 (13-22) mmHg. Transpulmonary pressure gradient (TPG) was 6.5 (3.5-10) mmHg and pulmonary vascular resistance (Rp) 2.65 WU*m2 (1.87-3.19). After pHTx, at immediate evaluation 2 weeks after pHTx PAP decreased to 20.5 (17-24) mmHg, PCWP 14.5 (10.5-18) mmHg (p < .05), LVEDP 16 (12.5-18) mmHg, TPG 6.5 (4-12) mmHg, Rp 1.49 (1.08-2.74) WU*m2 resp.at last invasive follow up 4.0 (1.4-6) years after pHTx, to PAP 19.5 (17-21) mmHg (p < .05), PCWP 13 (10.5-14.5) mmHg (p < .05), LVEDP 13 (10.5-14) mmHg, TPG 7 (5-9.5) mmHg, Rp 1.58 (1.38-2.19) WU*m2 (p < .05). In CHD patients PAP increased (p < .05) after pHTx at immediate evaluation and decreased until last follow-up (p < .05), while in CMP patients there was a continuous decline of mean PAP values immediately after HTx (p < .05).ConclusionsWhile PH before pHTx is frequent, after pHTx the normalization of PH starts immediately in CMP patients but is delayed in CHD patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] A Risk-Prediction Model for In-hospital Mortality After Heart Transplantation in US Children
    Almond, C. S.
    Gauvreau, K.
    Canter, C. E.
    Rajagopal, S. K.
    Piercey, G. E.
    Singh, T. P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) : 1240 - 1248
  • [2] Outcomes and risk factors for heart transplantation in children with congenital heart disease
    Alsoufi, Bahaaldin
    Deshpande, Shriprasad
    McCracken, Courtney
    Kogon, Brian
    Vincent, Robert
    Mahle, William
    Kanter, Kirk
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 150 (06) : 1455 - U143
  • [3] Pediatric heart transplant
    Barnes, Aliessa
    Gibson, William
    [J]. SEMINARS IN PEDIATRIC SURGERY, 2021, 30 (02)
  • [4] Bauer J, 1997, J HEART LUNG TRANSPL, V16, P1238
  • [5] Impact of pulmonary hypertension on transplant outcomes in pediatric cardiomyopathy patients
    Buddhe, Sujatha
    Du, Wei
    L'Ecuyer, Thomas
    [J]. PEDIATRIC TRANSPLANTATION, 2012, 16 (04) : 367 - 372
  • [6] Indications for heart transplantation in pediatric heart disease - A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group
    Canter, Charles E.
    Shaddy, Robert E.
    Bernstein, Daniel
    Hsu, Daphne T.
    Chrisant, Maryanne R. K.
    Kirklin, James K.
    Kanter, Kirk R.
    Higgins, Robert S. D.
    Blume, Elizabeth D.
    Rosenthal, David N.
    Boucek, Mark M.
    Uzark, Karen C.
    Friedman, Allen H.
    Young, James K.
    [J]. CIRCULATION, 2007, 115 (05) : 658 - 676
  • [7] Pediatric heart transplantation in the current era
    D'Addese, Laura
    Joong, Anna
    Burch, Michael
    Pahl, Elfriede
    [J]. CURRENT OPINION IN PEDIATRICS, 2019, 31 (05) : 583 - 591
  • [8] Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart Transplantation
    Daftari, Babak
    Alejos, Juan Carlos
    Perens, Gregory
    [J]. JOURNAL OF TRANSPLANTATION, 2010, 2010
  • [9] Effect of ischemic time on pediatric heart transplantation outcomes: is it the same for all allografts?
    Dani, Alia
    Vu, Quyen
    Thangappan, Karthik
    Huang, Bin
    Wittekind, Samuel
    Lorts, Angela
    Chin, Clifford
    Morales, David L. S.
    Zafar, Farhan
    [J]. PEDIATRIC TRANSPLANTATION, 2022, 26 (04)
  • [10] Decision-making for surgery in the management of patients with univentricular heart
    Davies, Ryan Robert
    Pizarro, Christian
    [J]. FRONTIERS IN PEDIATRICS, 2015, 3